CN1264559C - Medicine for treating cardiovascular and cerebrovascular diseases - Google Patents
Medicine for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN1264559C CN1264559C CN 200310107772 CN200310107772A CN1264559C CN 1264559 C CN1264559 C CN 1264559C CN 200310107772 CN200310107772 CN 200310107772 CN 200310107772 A CN200310107772 A CN 200310107772A CN 1264559 C CN1264559 C CN 1264559C
- Authority
- CN
- China
- Prior art keywords
- portions
- radix
- medicine
- roots
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a medicine for treating cardiovascular/cerebrovascular diseases. The medicine comprises 10 to 25 portions of rehmannia roots, 5 to 20 portions of gastrodia tubers, 5 to 15 portions of licorice roots, 5 to 20 portions of angelica, 5 to 20 portions of tuckahoe, 7.5 to 20 portions of ramulus cinnamomi, 5 to 20 portions of long-noded pit viper, 5 to 20 portions of kakuda figwort roots, 5 to 20 portions of scutellaria roots, 10 to 30 portions of achyranthes roots and 10 to 30 portions of earthworms. The present invention is used in the recovery period of cerebral hemorrhage, and has the functions of promoting the absorption of blood stasis, improving blood circulation and promoting the damaged cytothesis. When used for treating cerebral infarction, the present invention has the functions of anticoagulation, thrombolysis and reliable cerebral protection. The present invention has a stable improving function for hyperlipemia, hyperfibrinogenemia and blood hypercoagulabale states.
Description
(1), technical field
What the present invention relates to is a kind of medicine configuration product.Specifically a kind of medicine configuration product that are used for the treatment of cardiovascular and cerebrovascular disease.
(2), background technology
Present cardiovascular and cerebrovascular disease to period of disease rescues, the research of treatment aspect is more.But cardiovascular and cerebrovascular disease tends to stay some sequela after rescuing, and needs to recover for a long time and treatment.
(3), summary of the invention
The object of the present invention is to provide a kind of medicine that cardiovascular and cerebrovascular diseases such as cerebral hemorrhage convalescent period is had the treatment cardiovascular and cerebrovascular disease of excellent curative.
The object of the present invention is achieved like this: it contains Radix Rehmanniae 10-25 part, Rhizoma Gastrodiae 5-20 part, Radix Glycyrrhizae 5-15 part, Radix Angelicae Sinensis 5-20 part, Poria 5-20 part, Ramulus Cinnamomi 7.5-20 part, Agkistrodon 5-20 part, Radix Scutellariae 5-20 part, Radix Achyranthis Bidentatae 10-30 part and Pheretima 10-30 part.
The present invention can also comprise some features like this:
1, it also contains Concha Haliotidis 10-20 part, Concha Ostreae 10-30 part, Ramulus Uncariae Cum Uncis 10-20 part, Haematitum 20-50 part, Flos Chrysanthemi 15-50 part and Carapax et Plastrum Testudinis 5-25 part.
2, it also contains Rhizoma Atractylodis Macrocephalae 5-15 part, Rhizoma Chuanxiong 5-15 part, Radix Astragali 50-200 part and Radix Paeoniae Rubra 5-15 part.
Radix Rehmanniae among the present invention, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra have the merit of the circulation of qi promoting of nourishing blood; The Rhizoma Atractylodis Macrocephalae, Radix Scutellariae have the effect of brain-strengthening damp eliminating; Concha Ostreae, Haematitum, Carapax et Plastrum Testudinis, Ramulus Uncariae Cum Uncis have the effect of growing sun, suppressing the hyperactive liver to arrest the wind syndrome; Radix Achyranthis Bidentatae has the effect of suppressing the hyperactive liver conducting blood to flow downwards; Flos Chrysanthemi has the liver heat removing and eyesight improving effect; Pheretima has the bolt of oozing, anticoagulant, removing blood stasis effect; The Radix Astragali has the effect of replenishing QI and blood, the meridian dredging; Ramulus Cinnamomi can be treated myasthenia of limbs.Product of the present invention carries out compatibility with these raw materials, coordinates mutually between each raw material, has embodied the traditional Chinese medical science and has distinguished and allow principle, grows sun, replenishing QI and blood, the meridian dredging, treatment numbness, relieves dizziness, high fever, infantile convulsions, epilepsy, etc., eliminates the phlegm, induces sweat, calms the nerves, heat clearing away, has one's ideas straightened out.Be used for cerebral hemorrhage convalescent period, have to promote congestion to absorb, improve blood circulation, promote the effect that damaged cell is repaired.Be used for cerebral infarction and be plugged with the anticoagulant and thrombolytic effect.Reliable cerebral protection is arranged simultaneously, hyperlipidemia, hyperfibrinogenemia, high blood coagulation state are had stable improvement effect.
(4), the specific embodiment
For example the present invention is done in more detail below and describes:
Ratio in Radix Rehmanniae 10-25 part, Rhizoma Gastrodiae 5-20 part, Radix Glycyrrhizae 5-15 part, Radix Angelicae Sinensis 5-20 part, Poria 5-20 part, Ramulus Cinnamomi 7.5-20 part, Agkistrodon 5-20 part, Radix Scutellariae 5-20 part, Radix Achyranthis Bidentatae 10-30 part and Pheretima 10-30 part prepares raw material, each raw material is mixed, adopt the method for water extraction to extract active ingredient, make oral liquid or other dosage form.
Ratio in Radix Rehmanniae 10-25 part, Rhizoma Gastrodiae 5-20 part, Radix Glycyrrhizae 5-15 part, Radix Angelicae Sinensis 5-20 part, Poria 5-20 part, Ramulus Cinnamomi 7.5-20 part, Agkistrodon 5-20 part, Radix Scutellariae 5-20 part, Radix Achyranthis Bidentatae 10-30 part, Pheretima 10-30 part, Concha Haliotidis 10-20 part, Concha Ostreae 10-30 part, Ramulus Uncariae Cum Uncis 10-20 part, Haematitum 20-50 part, Flos Chrysanthemi 15-50 part and Carapax et Plastrum Testudinis 5-25 part prepares raw material, each raw material is mixed, adopt the method for water extraction to extract active ingredient, make oral liquid or other dosage form.Present embodiment is more suitable for using in the patient who suffers from vascular hypertension simultaneously.
Ratio in Radix Rehmanniae 10-25 part, Rhizoma Gastrodiae 5-20 part, Radix Glycyrrhizae 5-15 part, Radix Angelicae Sinensis 5-20 part, Poria 5-20 part, Ramulus Cinnamomi 7.5-20 part, Agkistrodon 5-20 part, Radix Scutellariae 5-20 part, Radix Achyranthis Bidentatae 10-30 part, Pheretima 10-30 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Rhizoma Chuanxiong 5-15 part, Radix Astragali 50-200 part and Radix Paeoniae Rubra 5-15 part prepares raw material, each raw material is mixed, adopt the method for water extraction to extract active ingredient, make oral liquid or other dosage form.Present embodiment is more suitable for using in the patient of low blood pressure.
Ratio in 15 parts of 15 parts of Radix Rehmanniae, 10 parts in Rhizoma Gastrodiae, 8 parts in Radix Glycyrrhizae, 15 parts of Radix Angelicae Sinensis, 10 parts in Poria, 15 parts of Ramulus Cinnamomi, 10 parts of Agkistrodons, 10 parts of Radix Scutellariae, 20 parts of Radix Achyranthis Bidentataes, 20 parts of Pheretimas, 15 parts of Concha Haliotidis, 20 parts of Concha Ostreaes, 15 parts of Ramulus Uncariae Cum Uncis, 30 parts of Haematitums, 30 parts of Flos Chrysanthemis and Carapax et Plastrum Testudiniss prepares raw material, each raw material is mixed, adopt the method for water extraction to extract active ingredient, make oral liquid or other dosage form.
Ratio in 10 parts of 15 parts of Radix Rehmanniae, 15 parts in Rhizoma Gastrodiae, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Angelicae Sinensis, 15 parts in Poria, 15 parts of Ramulus Cinnamomi, 10 parts of Agkistrodons, 15 parts of Radix Scutellariae, 15 parts of Radix Achyranthis Bidentataes, 20 parts of Pheretimas, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Rhizoma Chuanxiongs, 100 parts of the Radixs Astragali and Radix Paeoniae Rubra prepares raw material, each raw material is mixed, adopt the method for water extraction to extract active ingredient, make oral liquid or other dosage form.
Claims (3)
1, a kind of medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that: it contains Radix Rehmanniae 10-25 part, Rhizoma Gastrodiae 5-20 part, Radix Glycyrrhizae 5-15 part, Radix Angelicae Sinensis 5-20 part, Poria 5-20 part, Ramulus Cinnamomi 7.5-20 part, Agkistrodon 5-20 part, Radix Scutellariae 5-20 part, Radix Achyranthis Bidentatae 10-30 part and Pheretima 10-30 part.
2, the medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: it also contains Concha Haliotidis 10-20 part, Concha Ostreae 10-30 part, Ramulus Uncariae Cum Uncis 10-20 part, Haematitum 20-50 part, Flos Chrysanthemi 15-50 part and Carapax et Plastrum Testudinis 5-25 part.
3, the medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: it also contains Rhizoma Atractylodis Macrocephalae 5-15 part, Rhizoma Chuanxiong 5-15 part, Radix Astragali 50-200 part and Radix Paeoniae Rubra 5-15 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310107772 CN1264559C (en) | 2003-12-23 | 2003-12-23 | Medicine for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310107772 CN1264559C (en) | 2003-12-23 | 2003-12-23 | Medicine for treating cardiovascular and cerebrovascular diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1631382A CN1631382A (en) | 2005-06-29 |
CN1264559C true CN1264559C (en) | 2006-07-19 |
Family
ID=34843025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310107772 Expired - Fee Related CN1264559C (en) | 2003-12-23 | 2003-12-23 | Medicine for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1264559C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100795822B1 (en) * | 2006-03-24 | 2008-01-17 | 남종현 | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tee including the same as effective components and the preparation method thereof |
CN100457162C (en) * | 2006-06-27 | 2009-02-04 | 王静怡 | Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia |
CN104189115A (en) * | 2014-09-24 | 2014-12-10 | 山东省立医院 | Traditional Chinese medicine for recovery phase of cerebral hemorrhage |
CN104436068A (en) * | 2014-12-21 | 2015-03-25 | 魏国 | Traditional Chinese medicinal composition for treating cerebral infarction |
-
2003
- 2003-12-23 CN CN 200310107772 patent/CN1264559C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1631382A (en) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1457831A (en) | Dynamic medicine for channels and collaterals and blood vessel | |
CN1264559C (en) | Medicine for treating cardiovascular and cerebrovascular diseases | |
CN1159037C (en) | Medicine for treating apoplexy | |
CN1248724C (en) | Hair regenerating formulation and its production method | |
CN1231189A (en) | Traditional Chinese medicine for promoting blood circulation by removing blood stasis | |
CN1047317C (en) | Herb of linearstripe Rabdosia drink | |
CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
CN1228063C (en) | Medicine for treating liver disease | |
CN103908543A (en) | Traditional Chinese medicine for treating sequelae of apoplexy and preparation method thereof | |
CN1296076C (en) | Medicine for clearing skin toxin | |
CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
CN100493558C (en) | Oral liquid for apoplexy | |
CN103656314A (en) | Traditional Chinese medicinal preparation for treating hepatitis A | |
CN1626159A (en) | Method for preparing pills of quenching dizziness | |
CN106389824A (en) | Traditional Chinese medicine granules for promoting dispersing function of lung and preparation method thereof | |
CN1911406A (en) | Medicine for treating headache contg. pearl, root of herbaceous peony, rhizoma gastrodiae, root of bark of tree peony and centipede | |
CN1544030A (en) | Huanglian Shangqing Granule and preparation method thereof | |
CN1562327A (en) | Decoction of turning negative in five steps for virus of hepatitis B | |
CN1237425A (en) | Preparation method of liver-clearing jaundice-adating oral liquor | |
CN1289611A (en) | Quick-acting Chinese medicine for treating cirrhosis and its preparing process | |
CN1899546A (en) | Medicinal composition for treating hepatitis B | |
CN1238974A (en) | 'Xuanyun' pill for treating dizziness | |
CN1221269C (en) | Paralysis treating medicine bolus | |
CN1144117A (en) | Yigan medical capsule for curing hepatitis B | |
CN1352979A (en) | Chinese medicine for replenishing vital energy and promoting blood circulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |